We focused on understanding the role of vitamin D3 in treating chronic rhinosinusitis (CRS), a condition affecting the nasal passages and sinuses. Our study analyzed 200 patients with vitamin D deficiency, dividing them into two groups: one group was given oral vitamin D supplements, while the other received a placebo.
Over a span of three months, we monitored changes in vitamin D levels and symptoms using the Total Nasal Symptom Score (TNSS). Initially, the average vitamin D level was quite low at 12.31 ng/ml. Remarkably, after treatment, this level surged to 29.71 ng/ml, indicating a significant improvement.
Additionally, we observed a reduction in TNSS scores, showing that while the average score started at 11.92, it decreased by about 10.65 points after three months of vitamin D treatment. This significant drop highlights the positive impact vitamin D supplementation can have on alleviating symptoms of CRS.
Overall, our exploration revealed a previously high prevalence of vitamin D deficiency among CRS patients, suggesting that addressing this deficiency through supplementation can be beneficial in managing their symptoms effectively.